Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4269 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Positive test for Intrac pain relief drug

Dyloject utilizes the same active ingredient as Voltarol, but is given as a single, brief injection, whereas Voltarol requires a slow (30 minutes or longer) infusion of a

Positive study for Boehringer prostate drug

“Unlike terazosin, tamsulosin (Flomax) does not have to be titrated and patients receive a therapeutically effective dose on day one,” commented Dr Perinchery Narayan, director of the North

Positive trial for Aphton cancer drug

The drug, IGN311, targets cancer of the tissue that covers organs, and is applicable to breast, colon, gastric and pancreatic cancers. Twelve patients with epithelial cancers (breast, colorectal,

Stressgen granted US patent for HPV drug

This patent application extends the protection provided by the company’s original HspE7 patent granted in 2003 and covers human papillomavirus (HPV) fusion protein compositions. Announcement of the new

Bioniche says recalled product is safe

The investigation into Betac has shown that the product is free of microbial contamination. Betac was the subject of a voluntary Class 1 recall last month after one-third